Skip to main content
GRAL
NASDAQ Life Sciences

Galleri Revenue Up 14% but Net Loss Widens to $103.6M; FDA Decision Due Early Q1 2027

Tom Rudovsky · Reported by PR Newswire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$135.67
Mkt Cap
$6.417B
52W Low
$41.5
52W High
$166.475
52W Position info
227% above low
Off High info
19% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

GRAL has more than doubled off its 52-week low of $41.5.

Summary

Galleri revenue rose 14% year-over-year to $37.3 million, but total revenue grew only 4% to $37.5 million as development services revenue collapsed to $266 thousand from $3.4 million. The bottom line deteriorated: net loss widened 16% to $103.6 million and adjusted EBITDA loss grew 29% to $92.6 million, while adjusted gross margin fell to 42% from 55%. Sales and marketing spending jumped to $41.7 million from $25.5 million, and cost of screening revenue rose to $22.0 million from $15.9 million, so volume growth is coming at a heavy cost. Cash, equivalents and short-term marketable securities totaled $788.7 million at September 30, down from roughly $904 million at year-end 2025 — a burn rate that keeps financing risk on the table. The company reiterated it expects an FDA decision on Galleri by early Q1 2027, following the September advisory committee vote in favor and the NEJM/Nature Medicine publications.

At the time of this announcement, GRAL was trading at $135.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.4B. The 52-week trading range was $41.50 to $166.48. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

GRAL - Latest Insights

GRAL
Nov 05, 2026, 4:09 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $119.13
Real-time Price: $103.49 info
Change: -$15.64 (-13%) info
Market Cap: $4.462B info
GRAL
Sep 23, 2026, 6:17 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $108.52
Real-time Price: $103.49 info
Change: -$5.03 (-5%) info
Market Cap: $4.462B info
GRAL
Sep 23, 2026, 8:07 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $109.91
Real-time Price: $103.49 info
Change: -$6.42 (-6%) info
Market Cap: $4.462B info
GRAL
Sep 21, 2026, 4:34 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $107.97
Real-time Price: $103.49 info
Change: -$4.48 (-4%) info
Market Cap: $4.462B info
GRAL
Sep 21, 2026, 12:37 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $107.76
Real-time Price: $103.49 info
Change: -$4.27 (-4%) info
Market Cap: $4.462B info